Product Information
CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $1.2133 per GM under NDC 51672140208. Its NADAC has been published 106 times since Apr 17, 2024.
FDA first approved this application on Sep 2, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION
Calcipotriene and Betamethasone DipropionateStrength
50; 50 mg/g; ug/g
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
51672140208
Classification
Generic
Dosage Form
SUSPENSION
Route
TOPICAL
Effective Date
8/19/2026
Active Ingredients
BETAMETHASONE DIPROPIONATE; CALCIPOTRIENEApproval Type
Generic (ANDA)
FDA Application
ANDA213269FDA Approved
9/2/2020
TE Code
AB
On Market Since
9/2/2020
Pharmacological Classes
Price Statistics
The NADAC for CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION has been published 106 times since Apr 17, 2024, and over the history we have for it it has declined 75.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2133 per GM |
|---|---|
| All-time high | $4.8574 (May 15, 2024) |
| All-time low | $0.8269 (Sep 17, 2025) |
| 52-week high | $1.2133 |
| 52-week low | $0.8269 |
| Median price | $4.4529 |
| Average price | $2.8439 |
| Largest weekly change | -81.4% (Sep 17, 2025) |
| Weeks tracked | 106 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION, manufactured by Sun Pharmaceutical Industries Inc., is $1.2133 per GM (NDC 51672140208), effective Aug 19, 2026.
How has the price of CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION changed over time?
Over the history we have for it, the NADAC for CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION has declined 75.0%. It has been tracked across 106 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION?
Since Apr 17, 2024, the NADAC for CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION has ranged from a low of $0.8269 (Sep 17, 2025) to a high of $4.8574 (May 15, 2024), with a median of $4.4529 per GM.
Are there cheaper alternatives to CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION in a comparable dosage form, but none are currently priced below it.
Who manufactures CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION?
CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION (NDC 51672140208) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.